Skip to content
value.today
JogoHealth, Inc. logo

JogoHealth, Inc.

Formerly Neural Therapeutics, Inc.

Total raised
$9 M
4 rounds on record
Latest round
$2 M
Jun 2025
First round on record
Apr 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of JogoHealth, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2025$2 MNo. 4$2 to $10 million

JogoHealth, Inc.: Raise no. 4, Jun 2025

Investors in this round

2 investors had bought by the notice of Jul 25, 2025: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$80,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sanjai Murali · Executive Officer, Director
  • Siva Nadarajah · Executive Officer, Director
  • Ari Bousbib · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Certain amounts of the proceeds of the offering may be used to cover certain amounts of the operating expenses of the Issuer which may include, among other expenses, certain amounts of the salaries of the executive officers listed herein.”

Signed by Sanjai Murali, Ceo. Newest notice filed Jul 25, 2025. Read the notice at the SEC.

equitySEC
Jul 2023$3 MNo. 3$2 to $10 million

JogoHealth, Inc.: Raise no. 3, Jul 2023

Investors in this round

48 investors had bought by the notice of Aug 25, 2023: 48 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $8 M offered; $5 M still to sell
Smallest investment taken
$12,619
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$80,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sanjai Murali · Executive Officer, Director
  • Siva Nadarajah · Executive Officer, Director
  • Ari Bousbib · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Certain amounts of the proceeds of the offering may be used to cover certain amounts of the operating expenses of the Issuer which may include, among other expenses, certain amounts of the salaries of the executive officers listed herein.”

Signed by Sanjai Murali, Ceo. Newest notice filed Aug 25, 2023. Read the notice at the SEC.

equitySEC
Jul 2021$1 MNo. 2Under $2 million

JogoHealth, Inc.: Raise no. 2, Jul 2021

Investors in this round

4 investors had bought by the notice of Aug 30, 2021: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $1 M still to sell
Smallest investment taken
$12,500
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sanjai Murali · Executive Officer · CEO

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sanjai Murali, Ceo. Newest notice filed Aug 30, 2021. Read the notice at the SEC.

equitySEC
Apr 2019$2 MNo. 1$2 to $10 million

JogoHealth, Inc.: Raise no. 1, Apr 2019

Investors in this round

26 investors had bought by the notice of Nov 8, 2019: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $0 M still to sell
Smallest investment taken
$12,500
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sanjai Murali · Executive Officer · CEO

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sanjai Murali, Ceo. Newest notice filed Nov 8, 2019. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • JogoHealth, Inc. reported revenue of $274,267 for its most recent fiscal year (filed Apr 2025), up from $253,476 the year before.

    SEC Form C/A · Apr 2025

  • Net loss for the same year: $2.53 million.

    SEC Form C/A · Apr 2025

  • JogoHealth, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2025).

    SEC Form D · Jul 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2025

In its own words

How the company describes itself to search engines on its website, word for word.

“JOGO Health is a digital neurology platform that helps patients receive comprehensive care for neurological, chronic pain, neuromuscular, neuro pelveology, and neuro gastroenterology conditions.”

As of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of JogoHealth, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by JogoHealth, Inc.
NameRoleNamed in
Sanjai MuraliExecutive officerJul 2025
Siva NadarajahExecutive officerJul 2025
Ari BousbibDirectorJul 2025
Sanjai MuraliDirectorJul 2025
Siva NadarajahDirectorJul 2025